rs538312081
|
|
Colorectal Carcinoma
|
|
0.700 |
GeneticVariation
|
UNIPROT |
|
|
|
rs2854746
|
|
Colorectal Carcinoma
|
|
0.050 |
GeneticVariation
|
BEFREE |
Our results demonstrated that IGFBP3 rs2854746 C>G polymorphism increases susceptibility to the CRC (allele model: OR=1.167, 95% CI=1.095~1.244, p<0.001 and to the dominant gene model: OR=1.226, 95% CI=1.113~1.350, p<0.001); but IGFBP3 rs2854744 A>C has no significant association with the CRC susceptibility (allele model: OR=0.970, 95% CI=0.932~1.010, p=0.138; dominant gene model: OR=0.995, 95% CI=0.936~1.057, p=0.874).
|
30334445 |
2018 |
rs2854746
|
|
Colorectal Carcinoma
|
|
0.050 |
GeneticVariation
|
BEFREE |
This meta-analysis demonstrates that there is no association of IGFBP-3 gene rs2854744 and rs2854746 polymorphisms with CRC risk.
|
24464126 |
2014 |
rs2854746
|
|
Colorectal Carcinoma
|
|
0.050 |
GeneticVariation
|
BEFREE |
The results suggest that the IGFBP3 A-202C and Gly32Ala polymorphisms are not associated with colorectal cancer susceptibility.
|
23527244 |
2013 |
rs2854746
|
|
Colorectal Carcinoma
|
|
0.050 |
GeneticVariation
|
BEFREE |
The purpose of this study was to examine the association of genetic variants in IGF1 (rs6214, rs6220, and rs35767) and IGFBP3 (rs2854744 and rs2854746) with risk of colorectal polyps and colorectal cancer.
|
19784788 |
2010 |
rs2854746
|
|
Colorectal Carcinoma
|
|
0.050 |
GeneticVariation
|
BEFREE |
A CA repeat polymorphism, in the IGF1 gene, which is located 969 bp upstream from the transcription start site and the rs2854744 and rs2854746 single nucleotide polymorphisms (SNPs) in the IGFBP3 gene have been associated with the serum levels of the respective proteins and colorectal cancer (CRC), but the results are inconsistent.
|
18031946 |
2007 |
rs2854744
|
|
Colorectal Carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
Our results demonstrated that IGFBP3 rs2854746 C>G polymorphism increases susceptibility to the CRC (allele model: OR=1.167, 95% CI=1.095~1.244, p<0.001 and to the dominant gene model: OR=1.226, 95% CI=1.113~1.350, p<0.001); but IGFBP3 rs2854744 A>C has no significant association with the CRC susceptibility (allele model: OR=0.970, 95% CI=0.932~1.010, p=0.138; dominant gene model: OR=0.995, 95% CI=0.936~1.057, p=0.874).
|
30334445 |
2018 |
rs2854744
|
|
Colorectal Carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
We found no association between IGFBP-3 gene rs2854744 polymorphism and CRC (P > 0.05).
|
24464126 |
2014 |
rs2854744
|
|
Colorectal Carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
The purpose of this study was to examine the association of genetic variants in IGF1 (rs6214, rs6220, and rs35767) and IGFBP3 (rs2854744 and rs2854746) with risk of colorectal polyps and colorectal cancer.
|
19784788 |
2010 |
rs2854744
|
|
Colorectal Carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
A CA repeat polymorphism, in the IGF1 gene, which is located 969 bp upstream from the transcription start site and the rs2854744 and rs2854746 single nucleotide polymorphisms (SNPs) in the IGFBP3 gene have been associated with the serum levels of the respective proteins and colorectal cancer (CRC), but the results are inconsistent.
|
18031946 |
2007 |
rs3110697
|
|
Colorectal Carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
The associations of four single nucleotide polymorphisms (SNPs) in IGF-I (rs6214), IGFBP-3 (rs3110697), INSR (rs1052371), and IRS2 (rs2289046) genes with the risk of CRC were evaluated using a case-control design with 167 CRC cases and 277 controls by the PCR-RFLP method.
|
24175768 |
2013 |